Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Mar 26, 2019BD FACSDuet(TM) system raises the bar on flow cytometry automation offering a fully integrated sample-to-answer solution with the BD FACSLyric(TM) clinical flow cytometerBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVD certification for the BD FACSDuet(TM) automated flow cytometry system. The...
-
Mar 21, 2019
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to the recent letter from FDA to health care providers...
Mar 14, 2019Venovo(TM) Venous Stent proven safe and effective in iliac and femoral veinsBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo(TM)...
-
Feb 13, 2019BD WavelinQ™ 4F EndoAVF System Receives 510(k) Clearance from U.S. Food and Drug Administration
FRANKLIN LAKES, N.J., February 13, 2019 –BD (Becton, Dickinson and Company), a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration for...
-
Feb 5, 2019- As reported, revenues of $4.160 billion increased 35.1 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.160 billion for the first fiscal quarter ended December 31,...
-
Jan 24, 2019BD Nano(TM) Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the U.S. Food and Drug Administration 510(k) clearance of its second generation BD Nano(TM)...
-
Dec 20, 2018BD MAX(TM) Enteric Viral Panel Receives 510(k) Clearance from U.S. Food and Drug Administration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of its BD MAX(TM) enteric viral...
Dec 11, 2018BD FACSLyric(TM) Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program CertificationBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This...
-
Nov 29, 2018Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new software application designed to help hospitals and health systems...
-
Nov 13, 2018Fully-automated BD Phoenix(TM) CPO Detect Test Receives U.S. FDA Clearance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of the BD Phoenix(TM) CPO detect...
-
Nov 6, 2018- As reported, full fiscal year revenues of $15.983 billion increased 32.2 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.402 billion for the fourth fiscal quarter ended September 30,...
-
Oct 29, 2018
BD MedMined™ Surveillance Advisor has earned Meaningful Use Stage 3 (MU3) certification validating its ability to collect and properly report data around antimicrobial use and resistance data by...
-
Oct 23, 2018Brings Total Company Investment in Nebraska to $340 Million in Two Years
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to announce a $200 million...
Oct 17, 2018Company Joins Effort Alongside Rotary and Leading Global Health Organizations to Expand Vaccinations in IndiaBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a donation of 20 million syringes valued at $1 million to Rotary, a nonprofit...
-
Oct 16, 2018BD MAX(TM) MDR-TB Panel Obtains CE-IVD Status in Europe
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX(TM) MDR-TB panel in Europe. Clinicians can use the test...
-
Aug 28, 2018
BD (Becton, Dickinson and Company), Direct Relief, and the National Association of Community Health Centers (NACHC) recently awarded five community health centers with a total of $1 million in...
-
Aug 2, 2018
Click on the links below to view results for the 2018 third fiscal quarter: View document online PDF file of BD 2018 third fiscal quarter results About BD BD is one of the largest global medical...
Jul 26, 2018BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune SystemBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD(®) AbSeq assay to analyze protein expression at the...
-
Jul 12, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that...
-
Jul 9, 2018everlinQ(TM) endoAVF System Receives FDA De Novo Marketing Authorization
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops...
-
Jun 27, 2018
Alexandria, VA., June 27, 2018 – In an effort to improve evidence-based care in Free and Charitable Clinics using point-of-care testing results, BD (Becton, Dickinson and Company) (NYSE: BDX) in...
-
Jun 18, 2018Visit BD Booth #9 and 10 to Learn how the Most Common Invasive Procedure doesn’t Need to be One of the Most Complex
Copenhagen, June 20, 2018 - During the 5th annual World Congress on Vascular Access (WoCoVA) being held June 20-22 in Copenhagen, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
Jun 4, 2018BD Pyxis(TM) ES Refrigerator Expands Enterprise-wide Medication Management Solutions from BD to Improve Refrigerated Medication Management and Security
BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution BD Pyxis(TM) ES Refrigerator Expands Enterprise-wide Medication Management...
-
May 3, 2018
Click on the links below to view results for the 2018 second fiscal quarter: View document online PDF file of BD 2018 second fiscal quarter results About BD BD is one of the largest global medical...
-
Apr 27, 2018Alberto Mas to Lead Medical Segment;
BD Names Three Executives to Segment Leadership Roles Alberto Mas to Lead Medical Segment; Patrick Kaltenbach to Lead Life Sciences Segment; Bill Tozzi to Lead Interventional Segment on Interim Basis
Apr 26, 2018New Cell Sorter Extends BD's Robust Portfolio of Flow Cytometry Research SolutionsBD Launches BD FACSymphony(TM) S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types New Cell Sorter Extends BD's Robust Portfolio of Flow Cytometry Research Solutions FRANKLIN LAKES,...
Apr 19, 2018BD Synapsys(TM) Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)BD Unveils Suite of Diagnostic Informatics and Automation Innovations BD Synapsys(TM) Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and...
-
Mar 22, 2018
BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes FRANKLIN LAKES, N.J., March 22, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
-
Mar 5, 2018New BD Survey Conducted by HIMSS Analytics® Reveals Heightened Need for Seamless Integration of Disparate Technologies during Medication Transit
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its comprehensive approach to integrated, enterprise medication management to help...
-
Feb 20, 2018CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene(®) Blood ccfDNA tube within...
-
Feb 13, 2018The BD Onclarity(TM) HPV Assay can detect 14 high-risk HPV types and provide additional information to guide physician decision-making
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pre-market approval from the U.S. Food and Drug Administration...
-
Feb 6, 2018
Click on the links below to view results for the 2018 first fiscal quarter: View document online PDF file of BD 2018 first fiscal quarter results About BD BD is one of the largest global medical...
-
Feb 6, 2018- As reported, revenues of $3.080 billion increased 5.4 percent, or 3.7 percent on a currency-neutral basis, which includes an estimated 110 basis point adverse impact from the previously disclosed change in the U.S. dispensing business model.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $3.080 billion for the first fiscal quarter ended December 31,...
-
Jan 15, 2018New Test Provides Diagnostic Results Up to 10 Times Faster Than Traditional Tests
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points Health B.V., announced today that the companies obtained CE Mark for a...
-
Jan 12, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Preanalytical Systems...
-
Dec 29, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health...
-
Dec 28, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance by the Ministry of Commerce of the People's...
-
Dec 22, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's clearance by the U.S. Federal Trade Commission (FTC)...
-
Dec 11, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has established a Product Security Partnership Program that emphasizes collaboration...
-
Dec 4, 2017Experience the Advantage of Complete Medication Management at #ASHP17 BD Booth 721
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today revealed several technology innovations to further optimize the entire medication management...
-
Nov 16, 2017New BD HealthSight(TM) Platform for Enterprise Medication Management Takes System-Wide Approach to Make Medication Management Safer, Simpler and Smarter
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight(TM) platform...
-
Nov 16, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, issued the following statement regarding today's announcement by Merit Medical Systems, Inc. that it...
-
Nov 2, 2017
Click on the links below to view results for the 2017 fourth fiscal quarter and full year: View document online PDF file of BD 2017 fourth fiscal quarter and full year results About BD BD is one...
-
Oct 26, 2017
Mississauga, Ontario, Oct. 26, 2017 – In recognition of Canadian Patient Safety Week (CPSW), occurring Oct. 30 – Nov.3, BD (Becton, Dickinson and Company), a leading global medical technology...
Oct 25, 2017Company Also Celebrates 50 Years of Cannula Production in ColumbusBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60...
-
Sep 28, 2017
Mississauga, Ontario and Hamilton, Ontario - September 28, 2017 – BD (Becton, Dickinson and Company), a leading global medical technology company and the Canadian Society for Medical Laboratory...
-
Sep 26, 2017Fully-automated BD Phoenix(TM) CPO detect test helps detect dangerous pathogens
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch(1) of the first automated phenotypic test to detect and classify...
-
Sep 20, 2017New Molecular Assays Will be for Use on the BD MAX(TM) System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution...
Sep 19, 2017BD Ultra-Fine(TM) Micro 6mm Pen Needles Now AvailableBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the BD Ultra-Fine(TM) micro pen needle 6mm x 32G for use with...
Sep 12, 2017BD Rhapsody(TM) single cell analysis system launches for gene expression profiling, plans to expand for protein analysisBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single cell analysis with the ability to...